Thromboprophylaxis in hospitalized COVID-19 patients: the efficacy and safety of the approved hospital protocol
Emanuel Kolanko(Jagiellonian University), Anetta Undas(Institute of Cardiology), Anna Prokop-Staszecka(John Paul II Hospital), Małgorzata Konieczyńska(John Paul II Hospital), Elżbieta Broniatowska(Andrzej Frycz Modrzewski Krakow University), Piotr Kopiński(Nicolaus Copernicus University), Joanna Pudło(John Paul II Hospital), Aleksandra Kruk(John Paul II Hospital), Tomasz Senderek(Andrzej Frycz Modrzewski Krakow University)
Cited by 7
Related Papers
Predictors of neutrophil extracellular traps markers in type 2 diabetes mellitus: associations with a prothrombotic state and hypofibrinolysis
|Cardiovascular Diabetology|2019|67
The evolution of<i>in vitro</i>models of lung fibrosis: promising prospects for drug discovery
|European Respiratory Review|2024|43
Increased immunomodulatory capacity of human amniotic cells after activation by pro-inflammatory chemokines
|European Journal of Pharmacology|2019|25
Dynamics of Acute Liver Injury in Experimental Models of Hepatotoxicity in the Context of Their Implementation in Preclinical Studies on Stem Cell Therapy
|Frontiers in Bioscience-Landmark|2022|9
The relationship between amniotic epithelial cells and their microenvironment
|Journal of Applied Biomedicine|2015|8